1028842-99-0 Usage
General Description
3-(3-fluorophenyl)-1H-pyrazol-5-amine is an organic compound with the molecular formula C9H8FN3. It is a pyrazole derivative with a fluorinated phenyl group and an amine group attached to the pyrazole ring. 3-(3-fluorophenyl)-1H-pyrazol-5-amine(SALTDATA: FREE) is commonly used in the pharmaceutical and chemical industries for its potential biological and pharmacological activities. Its specific applications include its use as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. Additionally, it may also have potential applications in the field of medicinal chemistry for the development of novel drugs with therapeutic properties. 3-(3-fluorophenyl)-1H-pyrazol-5-amine(SALTDATA: FREE) is available in the form of free base.
Check Digit Verification of cas no
The CAS Registry Mumber 1028842-99-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,8,8,4 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1028842-99:
(9*1)+(8*0)+(7*2)+(6*8)+(5*8)+(4*4)+(3*2)+(2*9)+(1*9)=160
160 % 10 = 0
So 1028842-99-0 is a valid CAS Registry Number.
1028842-99-0Relevant articles and documents
Polysubstituted heterocyclic derivative, preparation method thereof and application of polysubstituted heterocyclic derivative in medicine
-
Paragraph 0035-0037; 0053; 0057-0058; 0158-0160, (2021/06/02)
The invention provides a polysubstituted heterocyclic derivative, a preparation method thereof and application of the polysubstituted heterocyclic derivative in medicine, and belongs to the technical field of medicinal chemistry. The polysubstituted heterocyclic derivative is a compound shown in a general formula I or II, a pharmaceutically acceptable salt or a solvate of the compound, and the compound can inhibit mRNA demethylase on the protease level and is used for treating diseases related to mRNA demethylase functions.
NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS
-
Page/Page column 111-112, (2008/12/07)
The present invention provides compounds of formula (I) and compositions thereof, methods of making them, and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory system.
